These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 9534987

  • 1. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Furlan V, Lantz O, Lecointe D, Delfraissy JF, Offret H.
    J Acquir Immune Defic Syndr; 1999 Nov 01; 22(3):228-34. PubMed ID: 10770342
    [Abstract] [Full Text] [Related]

  • 3. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 01; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 4. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 5. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C, RESTIMOP study team.
    AIDS; 2001 Jan 05; 15(1):23-31. PubMed ID: 11192865
    [Abstract] [Full Text] [Related]

  • 6. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 Jan 05; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 7. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May 05; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 8. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.
    Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD.
    AIDS; 2000 Jan 28; 14(2):173-80. PubMed ID: 10708288
    [Abstract] [Full Text] [Related]

  • 9. Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART.
    Waib LF, Bonon SH, Salles AC, Benard G, de Oliveira AC, Pannuti CS, Pedro Rde J, Costa SC.
    Rev Inst Med Trop Sao Paulo; 2007 Jan 28; 49(4):215-9. PubMed ID: 17823749
    [Abstract] [Full Text] [Related]

  • 10. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.
    Casado JL, Perez-Elías MJ, Martí-Belda P, Antela A, Suarez M, Ciancas E, Frutos B, Perez MD, Guerrero A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct 01; 19(2):130-4. PubMed ID: 9768621
    [Abstract] [Full Text] [Related]

  • 11. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF, Garcia RA, Mendoza AJ.
    Eur J Ophthalmol; 2005 Oct 01; 15(5):610-8. PubMed ID: 16167292
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.
    HIV Clin Trials; 2006 Oct 01; 7(1):1-9. PubMed ID: 16632459
    [Abstract] [Full Text] [Related]

  • 13. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan 01; 114(1):23-33. PubMed ID: 8540847
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.
    Retina; 2002 Jun 01; 22(3):268-77. PubMed ID: 12055458
    [Abstract] [Full Text] [Related]

  • 15. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
    Casado JL, Arrizabalaga J, Montes M, Martí-Belda P, Tural C, Pinilla J, Gutierrez C, Portu J, Schuurman R, Aguirrebengoa K.
    AIDS; 1999 Aug 20; 13(12):1497-502. PubMed ID: 10465073
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival.
    Bowen EF, Wilson P, Cope A, Sabin C, Griffiths P, Davey C, Johnson M, Emery V.
    AIDS; 1996 Nov 20; 10(13):1515-20. PubMed ID: 8931786
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
    Ries E, Mühlbauer B, Ruhswurm I, Krepler K, Derbolav A, Svolba G, Rieger A, Wedrich A.
    Ophthalmologica; 1998 Nov 20; 212(4):239-43. PubMed ID: 9672212
    [Abstract] [Full Text] [Related]

  • 18. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
    Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD.
    AIDS; 1999 Jul 09; 13(10):1203-6. PubMed ID: 10416523
    [Abstract] [Full Text] [Related]

  • 19. Current management of cytomegalovirus disease in patients with AIDS.
    Jacobson MA.
    AIDS Res Hum Retroviruses; 1994 Aug 09; 10(8):917-23. PubMed ID: 7811543
    [Abstract] [Full Text] [Related]

  • 20. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS.
    Retina; 2001 Aug 09; 21(4):339-43. PubMed ID: 11508879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.